Kerstin Rhiem, Silke Zachariae, Anke Waha, Sabine Grill, Anna Hester, Michael Golatta, Marion van Mackelenbergh, Tanja Fehm, Tanja Schlaiß, Tim Ripperger, Susanne Ledig, Cornelia Meisel, Dorothee Speiser, Kristina Veselinovic, Christopher Schröder, Isabell Witzel, Julia Gallwas, Bernhard H F Weber, Christine Solbach, Bariyhe Aktas, Eric Hahnen, Christoph Engel, Rita Schmutzler
INTRODUCTION: International guidelines recommend genetic testing for women with familial breast cancer at an expected prevalence of pathogenic germline variants (PVs) of at least 10%. In a study sample of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC), we have previously shown that women with TNBC diagnosed before the age of 50 years but without a family history of breast or ovarian cancer (sTNBC) meet this criterion. The present study investigates the PV prevalence in BRCA1, BRCA2, and nine additional cancer predisposition genes in an extended sTNBC study sample including a cohort of women with a later age at sTNBC diagnosis...
May 2023: Breast Care